Search
for
Sort by
Research 31–60 of 1000+
- Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality
- Prostate Carcinoma, what would be the best to do ?
- Testosterone Deficiency is Not Protective Against the Development of Adenocarcinoma of the Prostate in a Type 1 Diabetic Patient
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- 5-Alpha Reductase Inhibitors in Prostate Cancer: From Clinical Trials to Clinical Practice
- Possible association between androgenic alopecia and risk of prostate cancer and testicular germ cell tumor: a systematic review and meta-analysis
- Why are men with premature alopecia at higher risk of benign prostatic hyperplasia? And what about prostate cancer?
- Off-label prescriptions: patient safety first
- Urological Oncology: Testis Cancer and Advances in Oncological Therapy
- Role of 5 alpha-reductase inhibitors in the management of prostate cancer
- Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses
- Association of Spironolactone Use With Risk of Cancer
- Clinical and metabolic implications of obesity in prostate cancer: is testosterone a missing link?
- Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer
- The preventive and therapeutic efficacy of finasteride and dutasteride in TRAMP mice
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Effect of finasteride on prostate-specific antigen
- Defining the Localization and Molecular Characteristic of Minor Salivary Gland Label-Retaining Cells
- 5α-Reductase Inhibitors and Chemoprevention: The PCPT and Beyond
- Combined C3b and Factor B Autoantibodies and MPGN Type II
- The clinical applications of five-alpha reductase inhibitors.
- Synthesis of 17β-N-arylcarbamoylandrost-4-en-3-one derivatives and their anti-proliferative effect on human androgen-sensitive LNCaP cell line
- Dutasteride
- Clinical use of 5α-reductase inhibitors
- Treatment options for alopecia: an update, looking to the future
- This Month in Clinical Urology
- Prostate cancer update: 2007
- Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases